In a study modeling the cost-effectiveness of vaccination campaigns in Somalia – the country with the second largest number of refugees in 2012 – the use of Hib vaccine, PCV10, or both Hib and PCV10 were all found to be cost effective means to prevent excess morbidity and mortality from pneumonia in young Somali children. Such a vaccination campaign could conservatively reduce pneumonia cases and deaths by nearly 20%.
Full Citation:
Gargano L.M., Hajjeh R., and Cookson S.T.. 2015. Pneumonia prevention during a humanitarian emergency: Cost-effectiveness of Haemophilus Influenzae Type B conjugate vaccine and pneumococcal conjugate vaccine in Somalia. Prehospital and Disaster Medicine. 30(4).
Title of Article: Pneumonia prevention during a humanitarian emergency: Cost-effectiveness of Haemophilus Influenzae Type B conjugate vaccine and pneumococcal conjugate vaccine in Somalia
Author(s): Gargano L.M., Hajjeh R., and Cookson S.T.
Publication Year: 2015
Publication Name: Prehospital and Disaster Medicine
Publication Volume: 30(4)
Publication Source URL: https://www.ncbi.nlm.nih.gov/pubmed/26061190
DOI (Digital Object Identifier): 10.1017/S1049023X15004781
Topics: Conflict & Humanitarian Emergencies | Global Issues
Disease Vaccines: Haemophilus lnfluenzae type b (Hib) | Pneumococcal disease/PCV/PPSV | Pneumonia
Countries: Somalia
WHO Regions: Eastern Mediterranean